CUSIP: 45114M109
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,610,666
-
Share change
-
+1,082,099
-
Total reported value
-
$194,939,206
-
Put/Call ratio
-
39%
-
Price per share
-
$5.80
-
Number of holders
-
66
-
Value change
-
+$4,832,934
-
Number of buys
-
32
-
Number of sells
-
28
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2023
-
Previous quarter:
Q4 2022
Recent filing periods for CUSIP 45114M109:
Institutional Holders of ICOSAVAX INC - COM (ICVX) as of Q1 2023
As of 31 Mar 2023,
ICOSAVAX INC - COM (ICVX) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,610,666 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Qiming U.S. Ventures Management, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, ADAMS STREET PARTNERS LLC, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, and Rock Springs Capital Management LP.
This page lists
66
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.